We’re proud to share that UCB U.S. was recognized by Wheels for having the greenest fleet within the pharmaceutical sector with Tesla North America being the lead electric vehicle chosen by drivers. Swipe to learn more about our eco-friendly approach. #EarthDay2024 🌎

Attending #AANAM in Denver? Join UCB and renowned generalized #myastheniagravis (gMG) experts for an interactive lunch symposium on the importance of shared decision-making approaches within an era of new targeted therapies that harness the potential of gMG care. #MGstrong

This week we join the #neurology community at #AANAM to highlight our continued advances for the communities we serve. Read more about our efforts to improve patient quality of life as we collaborate with partners throughout the care journey.

For Media: UCB presents new data highlighting developments across expansive neurology portfolio at 76th #AANAM

Learn more: ucbusa.news/3VVtmTW

It's #NationalSiblingsDay and we are celebrating our #CDKL5 VIP siblings! These rare epilepsy sibs are often unselfish and dedicated. They can see past challenges, exhibiting compassion beyond their years. Learn about the VIP Sibling program:
cdkl5.com/blog/vip-sibli…

Siblings are a critical part of the care journey for someone living with seizures. For all of the siblings that double as caregivers, support systems, and advocates, we're celebrating you this #NationalSiblingsDay . 👫🏻

We're excited to unveil our new disease-state education campaign, Make HStory. Visit the site to read stories shared by those living with HS and access new resources for care management with your dermatologist. #HidradenitisSuppurativa

FOR MEDIA: UCB Launches Make HStory, an Educational Campaign Offering Resources and Support for Those Living with #HidradenitisSuppurativa

FOR MEDIA: UCB announces FDA accepts supplemental biologics license applications seeking approval for moderate-to-severe hidradenitis suppurativa and additional 2mL device presentations.

At UCB, we understand the power of listening to and learning from patient communities to help us deliver better outcomes. This #PurpleDay2024 , learn from rare #epilepsy leaders Karen and Veronica in our most recent episode of Raring to Listen.

Click to listen⬇ #EpilepsyAwareness

This #WomensHistoryMonth , we're proud to recognize two women leaders who have made a significant contribution to our organization - Patty Fritz, Head of U.S. Corporate Affairs, and Bianca Anderson, Digital Communications Lead, who have been named 2024 @HBANet winners. #HBAWOTY24

We're excited to be at the AANN conference and look forward to connecting with healthcare professionals dedicated to advancing the field for those living with and caring for someone with #epilepsy and #raresyndromes . #AANN2024

We are unwavering in our mission to address unmet needs among those living with dermatologic conditions like #HS , #psoriasis , and #psoriaticarthritis . Read more from Camille Lee, U.S. Head of Immunology, on how we’re working to raise the standard of care for these communities.

FOR MEDIA: Today, UCB announced new four-year data in moderate to severe plaque #psoriasis . #AAD2024 . Learn more.

This year’s #InternationalWomensDay is all about inspiring inclusion, and we couldn’t be more proud of the strong, intelligent women that make up team UCB.💜 #IWD2024

UCB is committed to improving the lives of people living with dermatological conditions like #psoriasis , psoriatic arthritis, and #hidradenitissuppurativa . We’re looking forward to sharing our progress at #AAD2024

Learn More: ucbusa.news/3IuIOyo

FOR MEDIA: UCB announced new 48-week Phase 3 analyses in moderate to severe hidradenitis suppurativa. #AAD2024 . Learn more.

Many people living with severe diseases experience delays in diagnosis and barriers to access healthcare services. Read how UCB is working to address these challenges and contribute to a more equitable and accessible healthcare landscape. #AnnualReport #Sustainability

In recognition of #RareDiseaseDay yesterday, UCB lit up the Blue Cross Blue Shield building in Chicago and our U.S. Headquarters in Atlanta to shine a light on the rare community. Together, we can generate awareness for the millions of people living with a rare disease.

Attending Muscular Dystrophy Association's Clinical and Scientific #MDAConference in Orlando? Join UCB for an industry forum to hear Tahseen Mozaffar, MD, at 7:00 AM on Tuesday, March 5, 2024.